Scholars Central

Conference abstract

Hepatitis A virus binding to its cellular receptor 1 (HAVCR1) blocks T-cell receptor and regulatory T-cell function: A novel viral immune escape mechanism

Authors: Gerardo Kaplan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

CD4+ regulatory T cells (Tregs) suppress immune responses and have a crucial role controlling self- tolerance. Pathogens activate Tregs to minimize immune-mediated tissue damage and delay or prevent clearance. For instance, chronic hepatitis C patients have a significant increase in the number of Tregs. In contrast, patients infected with hepatitis A virus (HAV), a Picornaviridae that causes acute hepatitis in humans and enters cells usurping the HAV cellular receptor 1 (HAVCR1), have limited Treg function. HAV-infection induces a poorly understood immunopathogenic processresulting in liver damage and the modulation of allergic and autoimmune responses. HAVCR1 is a significant allergy and autoimmunity determinant in man. Binding of HAV to HAVCR1 expressed on T-cells prevents the activation of the T-cell receptor and the Akt/PI3K pathway. Human Tregs constitutively express HAVCR1, and the HAV- HAVCR1 interaction shuts-off Treg function. Thus HAV infection represents a new paradigm in immune evasion in which the virus functions as an antagonist of HAVCR1 blocking Treg function and inducing a ?shock-and-awe? mechanism that overwhelms the immune system with anti-self responses in the presence of low levels of TGF-b, which limits strong T effector responses, and IL-22, which prevents liver damage. We propose that this unique immune evasion mechanism is responsible for the long-lasting modulation of the immune response in HAV-infected individuals, and could serve as a model to develop therapeutic strategies to prevent chronic liver infections, modulate autoimmune and allergic responses, and prevent transplant rejections. Furthermore, a vaccination strategy targeting HAVCR1 to block Treg function may enhance the immune response against problematic antigens.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Vaccines & Vaccination.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Vaccines & Vaccination
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Gerardo Kaplan”